Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-GLucose coTransporter-2 Inhibitors”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Large-scale testing (Phase 3)Looking for participantsNCT06982079
What this trial is testing

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Stage 5CKD Stage 4
Ain Shams University 60
Not applicableStudy completedNCT06964607
What this trial is testing

Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction

Who this might be right for
Sodium-glucose Cotransporter 2InhibitorsClinical Outcome+2 more
Tanta University 80
Not applicableNot Yet RecruitingNCT06739486
What this trial is testing

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more
Assiut University 100
Post-approval studies (Phase 4)Study completedNCT06268977
What this trial is testing

Adding SGLt2 Inhibitors to Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Assiut University 482
Testing effectiveness (Phase 2)Study completedNCT05834738
What this trial is testing

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 54
Post-approval studies (Phase 4)Study completedNCT03030222
What this trial is testing

Empagliflozin Impact on Hemodynamics in Patients With Heart Failure

Who this might be right for
Heart Failure
Saint Luke's Health System 65
Not applicableStudy completedNCT06903754
What this trial is testing

ISGLT2 in Patients Without DM With Acute MI

Who this might be right for
Acute Coronary SyndromesHeart Failure
Mohammed VI University Hospital 450
Not applicableNot Yet RecruitingNCT06668753
What this trial is testing

Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy

Who this might be right for
Effect of SGLT2 Inhibitors NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
Assiut University 114
Large-scale testing (Phase 3)Study completedNCT06117137
What this trial is testing

The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus

Who this might be right for
Fatty Liver, Nonalcoholic
Sohag University 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07146880
What this trial is testing

Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome

Who this might be right for
Brugada Syndrome (BrS)
National Taiwan University Hospital 10
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Post-approval studies (Phase 4)Study completedNCT05741658
What this trial is testing

The Fontan Dapagliflozin Pilot Study

Who this might be right for
Heart Failure
Johns Hopkins University 29
Post-approval studies (Phase 4)Study completedNCT05989503
What this trial is testing

Initiation of ARNi and SGLT2i in Patients With HFrEF

Who this might be right for
Heart Failure With Reduced Ejection Fraction
Universidade do Porto 62
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Not applicableUnknownNCT05261867
What this trial is testing

Cardioprotective Effect of SGLT2-I in Diabetic Patients With AMI (SGLT2-I AMI PROTECT Study)

Who this might be right for
Diabetes MellitusAcute Coronary Syndrome
IRCCS Azienda Ospedaliero-Universitaria di Bologna 800
Large-scale testing (Phase 3)Looking for participantsNCT07214818
What this trial is testing

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Mansoura University 75
Testing effectiveness (Phase 2)Study completedNCT06150924
What this trial is testing

Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

Who this might be right for
Chronic Kidney Disease
Mineralys Therapeutics Inc. 60
Early research (Phase 1)Looking for participantsNCT05521984
What this trial is testing

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Who this might be right for
Pediatric Brain TumorPediatric Solid Tumor
Washington University School of Medicine 20
Not applicableStudy completedNCT03939624
What this trial is testing

Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events

Who this might be right for
Type2 DiabetesMyocardial InfarctionIschemic Stroke+3 more
Canadian Network for Observational Drug Effect Studies, CNODES 419,734
Post-approval studies (Phase 4)Looking for participantsNCT07482943
What this trial is testing

The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

Who this might be right for
FontanHeart FailureDapagliflozin+2 more
The University of Hong Kong 30
Next Page